echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Wang Sheng's team collaborates to develop a new generation of anti-schizophrenia lead drugs

    Wang Sheng's team collaborates to develop a new generation of anti-schizophrenia lead drugs

    • Last Update: 2021-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>.


    With the rapid development of China's economy and society, people's life, work and other pressures have caused the incidence of mental illness to increase year by year


    The anti-schizophrenia drugs currently in clinical use can alleviate the positive symptoms, but most anti-schizophrenia drugs have limited or ineffective efficacy in improving negative symptoms and cognitive function


    Based on the historical context and pharmacological characteristics of drug development, the current anti-schizophrenia drugs can be divided into three generations


    The third-generation anti-schizophrenia drugs-aripiprazole, briprazole and cariprazine, are partial agonists of dopamine D 2 receptors


    Designing drugs with structural information as a guide is a popular route for the research and development of chemical small molecule drugs


    Researcher Wang Sheng from the Center of Excellence for Molecular Cells and researcher Cheng Jianjun from the iHuman Institute of ShanghaiTech University are the co-corresponding authors of the paper


    Article link: https://

    Figure a.


     

      Figure b.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.